These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 20521645
1. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus. Avellaneda G, Mundt E, Lee CW, Jadhao S, Suarez DL. Avian Dis; 2010 Mar; 54(1 Suppl):278-86. PubMed ID: 20521645 [Abstract] [Full Text] [Related]
3. A heterologous neuraminidase subtype strategy for the differentiation of infected and vaccinated animals (DIVA) for avian influenza virus using an alternative neuraminidase inhibition test. Avellaneda G, Sylte MJ, Lee CW, Suarez DL. Avian Dis; 2010 Mar; 54(1 Suppl):272-7. PubMed ID: 20521644 [Abstract] [Full Text] [Related]
6. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy. Liu Y, Mundt E, Mundt A, Sylte M, Suarez DL, Swayne DE, García M. Avian Dis; 2010 Mar; 54(1 Suppl):613-21. PubMed ID: 20521703 [Abstract] [Full Text] [Related]
8. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens. Zhao S, Jin M, Li H, Tan Y, Wang G, Zhang R, Chen H. Avian Dis; 2005 Dec; 49(4):488-93. PubMed ID: 16404988 [Abstract] [Full Text] [Related]
9. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens. Tarigan S, Indriani R, Durr PA, Ignjatovic J. Avian Pathol; 2015 Dec; 44(4):259-68. PubMed ID: 25915110 [Abstract] [Full Text] [Related]
11. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals. Swayne DE, Avellaneda G, Mickle TR, Pritchard N, Cruz J, Bublot M. Avian Dis; 2007 Sep; 51(3):697-704. PubMed ID: 17992929 [Abstract] [Full Text] [Related]
15. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
18. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks. Prel A, Le Gall-Reculé G, Cherbonnel M, Grasland B, Amelot M, Jestin V. Avian Dis; 2007 Mar 19; 51(1 Suppl):484-9. PubMed ID: 17494615 [Abstract] [Full Text] [Related]
19. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines. Stone H, Mitchell B, Brugh M. Avian Dis; 1997 Mar 19; 41(4):856-63. PubMed ID: 9454919 [Abstract] [Full Text] [Related]
20. A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens. Oliveira Cavalcanti M, Vaughn E, Capua I, Cattoli G, Terregino C, Harder T, Grund C, Vega C, Robles F, Franco J, Darji A, Arafa AS, Mundt E. Avian Pathol; 2017 Apr 19; 46(2):224-233. PubMed ID: 27807985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]